Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?

Literature DB >> 18816772

What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?

Claudio Fiocchi¹.

Abstract

Entities: Disease

Mesh：

Substances：
Inflammation Mediators

Year: 2008 PMID： 18816772 DOI： 10.1002/ibd.20618

Source DB: PubMed Journal: Inflamm Bowel Dis ISSN： 1078-0998 Impact factor: 5.325

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon.

Authors: Yumiko Iizuka; Atsukazu Kuwahara; Shin-Ichiro Karaki
Journal: J Physiol Sci Date: 2013-10-30 Impact factor: 2.781

2. The Macrophages and Intestinal Symbiosis.

Authors: Malgorzata Kloc; Ahmed Uosef; Mahmoud Elshawwaf; Ahmed Adel Abbas Abdelshafy; Kamal Mamdoh Kamal Elsaid; Jacek Z Kubiak; Rafik Mark Ghobrial
Journal: Results Probl Cell Differ Date: 2020

3. Protectin D1_{n-3 DPA} and resolvin D5_{n-3 DPA} are effectors of intestinal protection.

Authors: Thomas Gobbetti; Jesmond Dalli; Romain A Colas; Donata Federici Canova; Marius Aursnes; Delphine Bonnet; Laurent Alric; Nathalie Vergnolle; Celine Deraison; Trond V Hansen; Charles N Serhan; Mauro Perretti
Journal: Proc Natl Acad Sci U S A Date: 2017-03-29 Impact factor: 11.205

Review 4. Emerging targets in lipid-based therapy.

Authors: Stephanie C Tucker; Kenneth V Honn
Journal: Biochem Pharmacol Date: 2012-12-20 Impact factor: 5.858

Review 5. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.

Authors: Rafael I Jaén; Sergio Sánchez-García; María Fernández-Velasco; Lisardo Boscá; Patricia Prieto
Journal: Front Immunol Date: 2021-04-23 Impact factor: 7.561

Review 6. Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis.

Authors: Kuniaki Terato; Christopher T Do; Hiroshi Shionoya
Journal: Autoimmune Dis Date: 2015-03-12

7. Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period.

Authors: Natalia Torow; Kai Yu; Kasra Hassani; Jenny Freitag; Olga Schulz; Marijana Basic; Anne Brennecke; Tim Sparwasser; Norbert Wagner; André Bleich; Matthias Lochner; Siegfried Weiss; Reinhold Förster; Oliver Pabst; Mathias W Hornef
Journal: Nat Commun Date: 2015-07-21 Impact factor: 14.919

What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?

1. Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon.

2. The Macrophages and Intestinal Symbiosis.

3. Protectin D1_{n-3 DPA} and resolvin D5_{n-3 DPA} are effectors of intestinal protection.

Review 4. Emerging targets in lipid-based therapy.

Review 5. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.

Review 6. Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis.

7. Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period.

Review 8. The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals.

Review 9. Origin, Differentiation, and Function of Intestinal Macrophages.

10. Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis.

What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation?

1. Role of PGE2 in the colonic motility: PGE2 generates and enhances spontaneous contractions of longitudinal smooth muscle in the rat colon.

2. The Macrophages and Intestinal Symbiosis.

3. Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.

Review 4. Emerging targets in lipid-based therapy.

Review 5. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases.

Review 6. Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis.

7. Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period.

Review 8. The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals.

Review 9. Origin, Differentiation, and Function of Intestinal Macrophages.

10. Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis.

3. Protectin D1_{n-3 DPA} and resolvin D5_{n-3 DPA} are effectors of intestinal protection.